| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.25B | 41.75B | 37.11B | 35.40B | 33.21B | 25.94B |
| Gross Profit | 9.48B | 11.51B | 9.53B | 9.68B | 9.34B | 6.14B |
| EBITDA | 19.86B | 22.46B | 20.35B | 19.59B | 18.17B | 14.14B |
| Net Income | 2.98B | 3.37B | 3.51B | 4.09B | 3.13B | 1.79B |
Balance Sheet | ||||||
| Total Assets | 85.75B | 100.57B | 75.36B | 69.44B | 72.26B | 62.96B |
| Cash, Cash Equivalents and Short-Term Investments | 14.66B | 14.37B | 11.69B | 11.80B | 15.69B | 11.22B |
| Total Debt | 18.14B | 29.05B | 13.77B | 14.13B | 20.99B | 19.49B |
| Total Liabilities | 30.12B | 40.64B | 21.43B | 20.43B | 30.06B | 26.40B |
| Stockholders Equity | 38.33B | 40.48B | 37.40B | 34.12B | 29.58B | 26.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.64B | 2.71B | 4.32B | 4.00B | 1.59B |
| Operating Cash Flow | 0.00 | 20.14B | 17.47B | 18.33B | 17.03B | 11.42B |
| Investing Cash Flow | 0.00 | -28.68B | -14.61B | -14.66B | -12.19B | -9.65B |
| Financing Cash Flow | 0.00 | 11.84B | -3.56B | -9.62B | -382.90M | -2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥21.97T | 39.46 | 47.37% | 0.25% | 44.75% | 135.64% | |
77 Outperform | ¥712.39B | 24.84 | 12.66% | 2.28% | 7.69% | -19.63% | |
71 Outperform | ¥206.05B | 51.88 | 10.10% | 1.00% | -11.35% | -34.06% | |
71 Outperform | ¥513.17B | 22.63 | ― | 1.02% | 26.11% | 36.35% | |
63 Neutral | ¥92.61B | 17.02 | ― | 1.85% | 12.50% | -4.02% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥123.90B | -7.98 | ― | 2.45% | 1.60% | -74.21% |